Latest posts

Outside-walk-1024x751

Huntington's Disease

Developing Self-Sustaining Walking Groups for People with Huntington’s Disease

Posted on July 20, 2016 by Richard Haggerty

A newly-funded project seeks to empower people with Huntington’s disease to become stakeholders in their own walking groups as a way to maintain the benefits of exercise. Dr Una Jones; Katy Hamana; Professor Monica Busse; Dr Melanie Jones; Kay Holmes; Dr Sonia Vougioukalou; Professor Anne E Rosser Background Previous research by the Huntington’s disease (HD) Physiotherapy group at Cardiff Read moreabout Developing Self-Sustaining Walking Groups for People with Huntington’s Disease


shutterstock_111003710-1024x683

Huntington's Disease

Supporting Activity Engagement in People with Huntington’s Disease: A Phase II Evaluation

Posted on June 25, 2016 by Monica Busse-Morris

Dr Monica Busse; Dr Lori Quinn, Professor Anne Rosser, Professor Helen Dawes,Professor Kerry Hood Funded by the National Institute of Social Care and Health Research (NISCHR) in Wales We know that keeping active (both physically and socially) is important for any person who suffers with a chronic health condition. This can become very difficult for Read moreabout Supporting Activity Engagement in People with Huntington’s Disease: A Phase II Evaluation

Active-HD-logo wide 2

Huntington's Disease

Huntington’s Disease Physiotherapy Briefing

Posted on June 24, 2016 by Monica Busse-Morris

Early physiotherapy intervention plays a key role in management of Huntington’s disease (HD) over the life cycle of the disease. What is Huntington’s disease? HD is an inherited neurodegenerative disease for which there is no cure. Children of an affected individual have a 50/50 chance of inheriting the faulty HD gene. The mutation results in Read moreabout Huntington’s Disease Physiotherapy Briefing

LOGO_REPAIR-HD

Huntington's Disease

Repair-HD

Posted on June 23, 2016 by Monica Busse-Morris

Repair-HD proposes to establish all the components necessary to take human pluripotent stem cell-derived neuronal cells through to the point of ‘first-in-man’ clinical trial in Huntington’s disease (HD). The concept is to use HD as a ‘model’ disease to test the principle that an in vitro differentiated stem cell product can yield clinically useful structural Read moreabout Repair-HD

Disclaimer: Unless otherwise stated, the views contained within this blog are those of the author and do not necessarily represent the views of Cardiff University.